VIDEO: Improving Outcomes for Frontline Ocular Surface Disease Care

Improving clinical assessment of dry eye disease to help guide diagnosis, treatment and management.
Speakers: Derek N. Cunningham, OD, FAAO; Kelly Nichols, OD, MPH, PhD, FAAO; Paul Karpecki, OD, FAAO; and Doug Devries, OD, FAAO


Release Date:

March 15, 2017

Expiration Date:

March 15, 2018

Goal Statement: 

On completion of this educational activity, optometrists should understand why a thorough exam of the ocular surface and adnexa are essential aspects of optometric care, and be able to perform a proper evaluation of the ocular surface that will provide more definitive diagnoses, as well as highlight new research on the inflammatory pathway and ocular surface disease treatments.


Faculty/Editorial Board:

Derek N. Cunningham, OD, FAAO; Kelly Nichols, OD, MPH, PhD, FAAO; Paul Karpecki, OD, FAAO; and Doug Devries, OD, FAAO

Credit Statement: 

This course is COPE approved for 2 hours of CE credit. COPE ID is 52628-AS. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.

Joint-Sponsorship Statement: 

This continuing education course is joint sponsored by the University of Alabama School of Optometry.

Disclosure Statement: 

Dr. Cunningham is a consultant for Alcon, Allergan, Bausch + Lomb, TearLab and Abbot Medical Optics, and serves on the speaker’s bureau for Alcon, Allergan, Bausch + Lomb and Bio-Tissue. 
Dr. Nichols 
is a consultant for Bruder Healthcare Company, InSite Vision, Parion Pharmaceuticals, SARcode Bioscience, Shire Pharmaceuticals, Sun Pharmaceuticals, Kala Pharmaceutical, Eleven Biotherapeutics, Science Based Health, Allergan, Santen Pharmaceutical. 
Dr. Karpecki 
is a consultant for AcuFocus, Alcon, Abbott Medical Optics, Akorn, Allergan, Arctic Dx, Bausch + Lomb, Bio-Tissue, Bruder Healthcare, Beaver-Visitec, Eyes4Lives, OcuSoft, Freedom Meditech, Focus Labs, Eyemaginations, J&J, iCare USA, Konan Medical, Regeneron, Enchroma, Essilor, Eye Solutions, SightRisk, Reichert, Cambium Medical Technologies, Shire Pharmaceuticals, Science Based Health, Smart Vision Labs, TearScience, Topcon, TLC Vision, Vision Care Inc., Vmax and Visiometrics; a research grant principal investigator for Eleven BioTherapeutics, Fera Pharmaceuticals, Shire Pharmaceuticals; has received honoraria for the speaker’s bureaus of Glaukos and Oculus; is director/clinical advisor for Optometric Medical Solutions; and is on the board of directors for TearLab. 
Dr. Devries is on the advisory board for Allergan, Odyssey Medical Technologies, Bausch + Lomb, TearLab and Essilor; he is on the speaker’s bureau for Allergan, Odyssey Medical Technologies and OcuSoft.


Supported by: An unrestricted educational grant from Shire.



Watch this online distance learning course and click the link below to take the exam for 2 hours of CE credit.